The Oncology Institute, Inc. TOI Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from The Oncology Institute, Inc.’s reported figures.
Based on the most recent quarter.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s current ratio?
- The Oncology Institute, Inc. (TOI) reported current ratio of 1.5× in Q1 2026.
- How has The Oncology Institute, Inc.'s current ratio changed year-over-year?
- The Oncology Institute, Inc.'s current ratio decreased by 17.9% year-over-year, from 1.8× to 1.5×.
- What is the long-term trend for The Oncology Institute, Inc.'s current ratio?
- Over 5 years (2020 to 2025), The Oncology Institute, Inc.'s current ratio has grown at a 8.9% compound annual growth rate (CAGR), from 1× to 1.6×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.